Clinical Trial Update: Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 neoadjuvant study of lazertinib, with or without chemotherapy, in patients with EGFR-mutated resectable non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Lazertinib (lazertinib)

Snippet

Sponsor: Yonsei University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING